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Abstract. We have followed the internalization path- 
way of both epidermal growth factor (EGF) and its 
receptor in human epidermoid carcinoma (A431) 
cells. Using EGF conjugated with horseradish peroxi- 
dase and anti-receptor monoclonal antibodies (TL5 
and EGFR 1) coupled either directly or indirectly to 
colloidal gold we have identified an extensive elabora- 
tion of endosomal compartments, consisting of a pe- 
ripheral branching network of tubular cisternae con- 
nected to vacuolar elements that contain small vesi- 
cles and a pericentriolar compartment consisting of a 
tubular cisternal network connected to multivesicular 
bodies. Immunocytochemistry  on frozen thin sections 
using receptor-specific antibody-gold revealed that at 
4"C in the presence of EGF, receptors were mainly on 
the plasma membrane and, to a lesser extent, within 
some elements of both the peripheral and pericentrio- 
lar endosomal compartments. Upon warming to 37"C 
there was an EGF-dependent redistribution of most 
binding sites, first to the peripheral endosome com- 
partment and then to the pericentriolar compartment 
and lysosomes. Upon warming only to 20"C the li- 
gand-receptor complex accumulated in the pericen- 
triolar compartment. 
Acid phosphatase cytochemistry identifies hydro- 
lytic activity only within secondary lysosomes and 
trans cisternae of the Golgi stacks. Together these ob- 
servations suggest that the prelysosomal endosome 
compartment extends to the pericentriolar complex 
and that the transfer of EGF receptor complexes to 
the acid phosphatase-positive lysosome involves a dis- 
continuous, temperature-dependent step. 
E 
PIDERMAL growth factor (EGF)  1  is a potent mitogenic 
polypeptide, which, upon binding to specific receptors 
on the plasma membrane of its target cell, initiates a 
chain ofintracellular events that have been studied extensively 
(1, 4-6,  12, 26, 28, 35, 38). By the use of labeled derivatives 
of EGF it has been shown both biochemically and morpho- 
logically that ceil-bound EGF is rapidly internalized by its 
target cells into an endosomal compartment  and is subse- 
quently degraded in lysosomes (5,  16,  17,  30, 34). In most 
cell types continuous incubation at 37"C in the presence of 
EGF results not only in the degradation of EGF but also in 
the down-regulation of  the EGF receptor. This led to the idea, 
for which Krupp et at. (29) and Stoscheck and Carpenter (36) 
have recently provided direct biochemical evidence, that most 
internalized  EGF  receptors are  degraded along with  their 
bound ligand. 
Morphological experiments by McKanna et al. (30) using 
monomeric ferritin coupled to EGF indirectly demonstrated 
that the EGF receptor in A431 cells is internalized along with 
EGF to multivesicular bodies (MVBs) and subsequently to 
lysosomes. More recently Beguinot et al. (2) provided direct 
' Abbreviations  used in this paper."  EGF, epidermal growth factor; HRP, horse- 
radish peroxidase;  MVB, multivesicular body. 
morphological evidence that  down-regulation of the  EGF 
receptor in KB cells is due to receptor internalization into an 
endosomal compartment  followed by degradation in lyso- 
somes. 
Much of the work on internalization and processing of the 
EGF receptor and its ligand has been carried out in epider- 
moid  carcinoma (A431) cells, mainly because of the large 
number of receptors for EGF that these cells express ( 1-3 × 
106/cell). However, although  EGF receptors have recently 
been identified by immunocytochemistry in these cells (3), 
the morphological pathway of internalization  of the  EGF 
receptor has so far not been documented. Two monoclonal 
antibodies, TL5 (35) and EGFR1 (39), have been described 
that recognize, respectively,  the carbohydrate domain and the 
protein backbone of the EGF receptor. Neither of these anti- 
bodies competes for the binding of EGF to its receptor. By 
using these antibodies and immunogold cytochemical tech- 
niques on  ultrathin  frozen sections we  have been able to 
localize the EGF receptor in EGF-stimulated A431 cells. By 
incubating A431 cells with conjugates of EGF-horseradish 
peroxidase (HRP) we have also been able to follow the path- 
way taken by internalized peptide. Finally, by demonstrating 
acid  phosphatase  activity within  EGF-stimulated cells, we 
have examined  the  relationship between the  prelysosomal 
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essing the internalized receptor complexes. 
Materials and Methods 
Cell Culture and Incubation with Tracers 
A431 cells were cultured  in Dulbecco's  modified  Eagle's medium,  10%  fetal 
calfsernm on 3-cm-diam petri dishes. Before each experiment they were rinsed 
free of serum and incubated  for l h in serum-free DME. They were incubated 
with the various tracers as described in the text, and at each temperature change 
the cells were transferred directly to medium prewarmed  or precooled to the 
appropriate temperature. 
For peroxidase immunocytochemistry  ceils were fixed in dilute Karnovsky 
fluid (27) and incubated in a diaminobenzidine  substrate bath as described by 
Graham and Karnovsky  (14). They were then post-osmicated and embedded 
in Epon. Sections cut on a Sorvall Porter Blum MT2-B (DuPont Instruments, 
Newtown, CT) were examined in a Philips 301 electron microscope. 
EGF-HRP Conjugate 
EGF purified from mouse salivary glands was a gift from Dr. H. Gregory, ICi 
Pharmaceuticals,  Macclesfield, Cheshire, England. HRP (type II) was obtained 
from Sigma, Poole, Dorset, England. The conjugate was prepared using 200 ug 
EGF and 2.5  nag HRP using N-succinimidyl  3-(2 pyridyldithio)  propionate 
heterobifunctional  reagent as recommended  by the manufacturers (Pharmacia, 
Milton  Keynes,  England).  They  were  then  dialyzed  to  remove  unrcacted 
reagent. The HRP was activated with dithiothreitol  and chromatographed  on 
Sephadex G25. The activated HRP and EGF were then reacted together for 2 
d at 5°C. Finally, free EGF was removed from the conjugate by filtration on a 
YM IO Amicon filter (Amicon Corp., Danvers, MA). The preparation  of this 
conjugate is essentially the same as that described and characterized previously 
(41). Using ]251-EGF to trace label the EGF indicated a molar ratio of EGF to 
HRP of l: l0 and suggested that there were substantial amounts of free HRP in 
the  preparation.  However,  previous  studies  employing  free  HRP  with  the 
protocol used in this study (18) have shown that in A431 cells the binding and 
uptake of free HRP is negligible. 
Manufacture of TLS-Colloidal Gold Complexes 
Colloidal gold (~12-nm diam) was made according to the standard methods of 
Horisberger and Rosset (25) and Frens (10), and titrated to pH 7.5 with aqueous 
K2CO3. To prepare the complex, TL5 was dialyzed overnight against 0.005 M 
NaC1 and mixed with the colloidal gold according to the method described by 
Geoghegan and Ackerman (l l). Carbowax was added at a final concentration 
of 0.01%  before centrifugation  at 20,000 g  for 20 rain and resuspension  in 
phosphate-buffered saline (PBS) + 0.01% carbowax. The TL5-gold conjugate 
was stored at 5"C. For immunocytochemistry,  TL5-gold was washed by cen- 
trifugation in PBS containing 0.01% carbowax on a Beckman airfuge (Beckman 
Instruments inc., Palo Alto, CA) at 100,000 g for l rain and then resuspended 
in PBS + 0.1% bovine serum albumin (BSA) and 0.01% carbowax. Electron 
microscope examination  of  the gold conjugate before use revealed that the gold 
was monodisperse. 
Manufacture of  Protein A-Colloidal Gold Conjugates 
Colloidal gold (~8-nm diam) was made according to the standard  method of 
Faulk and Taylor (8) and titrated to oH 7.5 with 0.01 M acetic acid. The gold 
was stabilized by the addition of a solution of  protein A (Pharmacia) according 
to the method of Geoghegan and Ackerman  (1 I). Carbowax was added  at a 
final concentration  of  0.01% before centrifugation twice at 50,000 g for 60 rain 
and resuspension  in 0.01% carbowax after the first wash and 20 mM Tris- 
buffered saline, pH 8.3, containing 0. 1% BSA and 0.02% azide after the second 
wash. The protein A-gold conjugate was stored at 5"C. For immunocytochem- 
istry, protein  A-gold was washed by centrifugation  in PBS containing  0.01% 
carbowax and 0.1% BSA in a Beckman airfuge at  100,000 g for 2 rain  and 
then resuspended in PBS + 0.t% BSA and 0.01% carbowax. 
Immunocytochemistry 
A431 cells were fixed for 30 min in 8% paraformaldehyde in phosphate buffer, 
pH 7.4 (TL5), or for 60 min in 2% paraformaldehyde  + 0.05% glutaraldehyde 
in phosphate buffer pH 7.4 (EGFRI), then scraped off the dish and pelleted in 
a  Beckman  microfuge. Small (0.5 mm  j)  pieces of the pellet were frozen in 
liquid nitrogen, cryoscctioned, and immunolabeled  essentially as first described 
by  Tokuyasu  (37). The  sections  were either  labeled with  TL5  coupled  to 
colloidal gold for 45  min or incubated  with EGFR1  for 30 rain followed by 
protein  A-gold for 20 rain,  then washed for 20 min in five changes of PBS. 
Staining and embedding were carried out according to the method described 
by Griffiths et al. (t5). The sections were examined at 80 keV in a Philips 301 
electron microscope. 
For combined acid phosphatase cytochemistry and immunolabeling of EGF 
receptors on frozen thin sections, A431 cells were fixed in 2% paraformalde- 
hyde/0.05%  giutaraldehyde and then processed as described by Robinson and 
Karnovsky (33) using cerium as the capture  reagent. Control  preparations  in 
which  sodium  beta-glycerophosphate  was omitted  from the  substrate  bath 
showed no reaction product  even after prolonged incubations  (120 min). The 
acid  phosphatase  staining  was  followed by  freezing  and  cryosectioning  as 
described above. Thin frozen sections were incubated  with EGFRI and 8-rim 
protein A-gold and processed for microscopy. Acid phosphatasc stained mate- 
rial was also processed for Epon embedding. 
Results 
In  recent  studies  in  which  the  uptake  and  processing  of 
transferrin and transferrin receptors were followed in A431 
cells, two endosome compartments were described (23,  24). 
The peripheral compartment lying immediately beneath the 
plasma membrane consists of a branching network of tubular 
cisternae connected to vacuolar elements that contain small 
vesicles. The juxtanuclear compartment consists of a tubular 
cisternal network connected to MVBs and also includes ap- 
parently free lysosome-like bodies. For the present work on 
EGF-ligand receptor complexes, we made preliminary studies 
using EGF-peroxidase and anti-transferrin receptor antibody- 
gold. The extensive co-localization of  the two tracers suggested 
that both  of the  endosome compartments identified  previ- 
ously were involved in processing EGF. 
Since EGF stimulation is known to induce both receptor- 
mediated uptake and fluid-phase endocytosis in A431  cells 
we have adopted an  experimental protocol that  minimizes 
the fluid phase uptake of EGF. This protocol involves incu- 
bation of the cells at 5"C in the presence of EGF, followed by 
rinsing in the cold and transfer to EGF-free medium at either 
20 or 37"C. 20°C  incubations were employed because it has 
been shown in hepatocytes that at this temperature the trans- 
fer of endocytosed ligand to lysosomes is inhibited  (7).  By 
comparing compartments labeled at 37 and 20"C some indi- 
cation of the extent of the prelysosomal compartments may 
therefore be obtained. Before proceeding with tracer experi- 
ments we examined the effect of these various temperature 
changes on the morphological appearance of the two previ- 
ously described endosome compartments in  both  unstimu- 
lated and EGF-stimulated cells. 
Effect of Temperature and EGF Stimulation on the 
Organization of  the Endosome Compartments 
In cells incubated at 5"C for 30 rain, rinsed at 5"C, and then 
warmed to 20 or 37"C for up to 60 min, the organization of 
the peripheral endosome compartment was essentially as de- 
scribed previously. In cells warmed only to 37"C for 60 min, 
however, the juxtanuclear area became dominated by second- 
ary lysosome-like structures containing myelin figures. In cells 
warmed to 20"C the number ofautophagosome-like  structures 
in the juxtanuclear area was greatly increased. 
In cells incubated with EGF-HRP for 30 min at 5"C, rinsed 
at 5"C, and then warmed to 20 to 37"C, the cell periphery was 
seen,  by light  microscopy, to  ruffle extensively during  the 
earlier phases of the warm-up period. After this ruffling activ- 
ity,  examination by electron  microscopy identified  the  ap- 
pearance of large electron-lucent vacuoles in the peripheral 
cytoplasm and an increase in the number of tubular cisternae 
and vesicle-containing vacuolar elements. In cells incubated 
501  Miller et al. Localization of  EGF Receptor Figure 1.  A431 cell incubated with EGF-HRP at 5"C for 30 min and then transferred to EGF-free medium at 20°C for 60 min. EGF-HRP 
reaction product is seen in the cisternal and MVB elements of the pericentriolar endosome compartment. The endosomal elements surround 
the centrioles (C).  Inset:  Pericentriolar endosome compartment with EGF-HRP  reaction product  in  distended cisternae containing small 
vesicles (arrow). Bar, 200 nm. 
for  30  min  at  5°C  in  the  presence of EGF-HRP,  reaction 
product was distributed evenly over the plasma membrane. 
Upon transfer to  warm medium,  reaction product became 
concentrated within the tubular cisternae and vesicle-contain- 
ing vacuolar elements of the peripheral endosome compart- 
ment. If  instead of  with EGF-HRP the cells were preincubated 
with free EGF at 5°C and then transferred to warmed medium 
containing free HRP, reaction product was observed in the 
larger electron-lucent vacuoles. This result confirms the earlier 
observations of Haigler et al.,  who used essentially the same 
protocol with EGF-ferritin and HRP (17)  and showed that, 
whereas EGF induces fluid-phase endocytosis in these cells, 
the prebound EGF ligand is preferentially sequestered within 
endosomes derived by receptor-mediated uptake. 
After incubation in EGF-HRP at 5°C, rinsing, and warming 
to 37°C, peroxidase reaction product began to appear in the 
juxtanuclear area after 15 rain. At 20°C this distribution was 
not observed until after 30 min. Under the 370C incubation 
conditions  HRP  reaction  product  in  the juxtanuclear  area 
was distributed throughout a  branching smooth-surfaced re- 
ticulum of  tubular cisternae, which was occasionally distended 
and contained small vesicles.  Many MVBs also became la- 
beled. These cisternal and vacuolar structures lay within the 
vicinity  of the  Golgi  area  as  defined  by the  characteristic 
stacks of flattened cisternae, but their most obvious relation- 
ship was with the centriolar complex (Fig.  l). In appropriate 
section planes, the tubular cisternae and MVBs were seen to 
encircle the centrioles, the microtubules that radiate from the 
center of the complex extending between them.  Lysosome- 
like structures also occurred in the pericentriolar region, and 
after incubations of 60 min at 37°C many of them contained 
peroxidase reaction product. 
At 20°C and with incubations of up to 120 min, the number 
and  distribution  of MVBs  in  the  pericentriolar  area  were 
similar to that observed at  15 min, but the number of auto- 
phagosome-like structures  significantly increased.  In prepa- 
rations incubated at 20°C for >_30 min EGF peroxidase in the 
pericentriolar area appeared to be confined to the MVBs and 
their associated cisternae, 
Distribution of TL5 ,4ntibody/Gold and EGFR1- 
Protein A-GoM Complexes in ,4431 Cells 
In  general,  all  of the  morphological  features  identified  in 
conventional thin sections were identifiable in ultrathin frozen 
sections, and both antibodies localized the EGF receptor to 
identical  cellular  organeUes.  However,  a  difference  in  the 
density of labeling was observed between the two antibodies 
in that TL5 labeled the plasma membrane more heavily than 
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receptor had  been induced  to  internalize.  This will  be dis- 
cussed further below. In cells incubated at 5°C with EGF and 
fixed without warming, labeling was heaviest along the plasma 
membrane (Fig.  2).  Within  these  cells peripheral  vacuoles 
containing vesicles and occasional MVBs and lysosomes were 
also labeled but at a low level. Very occasionally gold particles 
were also observed over the flattened cisternae of the Golgi 
complex. 
In cells preincubated at 5"C with EGF and then warmed to 
37"C for 15 min the extensive peripheral endosome compart- 
ment observed in  EGF-HRP-stimulated cells was the  most 
heavily labeled compartment. Gold particles were distributed 
throughout the peripheral cisternae and were associated with 
both the limiting membrane and the vesicles of the vacuolar 
structures (Figs. 3 and 4). 
After 30 min at 37"C,  the cisternal elements, MVBs, and 
lysosome-like structures  that  characterize the  pericentriolar 
area became the most heavily labeled compartments. In fro- 
zen thin  section  preparations the  morphology of the  MVB 
population appeared much more heterogeneous than in con- 
ventional  resin-embedded sections.  Some MVBs contained 
many tightly  packed  vesicles,  and  others,  more  similar to 
those of  the peripheral compartment, contained fewer, usually 
larger vesicles (Fig.  4). Within these labeled MVBs gold par- 
ticles were predominantly associated with the internal vesicles. 
With incubations at 20"C pericentriolar MVBs were very 
heavily labeled, most containing many densely packed vesi- 
cles.  Again,  most  of the  labeling  was  associated  with  the 
internal vesicles of these MVBs. 
Distribution of  Lysosomal Hydrolases within the 
Endosome Pathway 
Although incubations at 20"C  suggest  that the prelysosomal 
endosome extends to the MVB-cisternae of the pericentriolar 
complex it was important to identify the distribution of acid 
hydrolase-containing compartments in this area. Acid phos- 
phatase  activity  was  therefore  displayed  using  the  cerium 
capture method of Robinson and Karnovsky (33).  In Epon 
sections of A431  cells acid phosphatase activity was distrib- 
uted  throughout  the  trans-most cisternae  of the  flattened 
Golgi stack and within well-defined secondary lysosomal ele- 
ments. However, many of the vacuolar elements in the peri- 
centriolar area were acid phosphatase negative. In thick (800 
nm to 1 #m) sections, it was clear that these elements, which 
were probably endosomal,  were not  connected to the  acid 
phosphatase-positive elements,  even though  they often lay 
immediately adjacent to them (Fig.  5). 
Labeling EGF-stimulated acid phosphatase-stained prepa- 
rations  with  the  EGFRI-protein A  gold technique  demon- 
strated that at 20"C  most of the MVBs in the pericentriolar 
area that contain EGF receptors lack acid phosphatase reac- 
tion  product.  Conversely, the  acid phosphatase-positive ly- 
sosomes rarely label with EGFRI. At 37"C and after incuba- 
Figure 2.  A431  cell incubated with EGF-HRP for 30 min at 5"C.  Thin-frozen section labeled with TL5 antibody-gold. Labeling is heaviest 
along the plasma membrane (prn). A peripheral vacuole containing vesicles (Is) and membrane-bound cisternal elements within the cytoplasm 
(arrows) are also labeled. Inset: TL5 antibody-gold labeling of the plasma membrane. Bar, 200 nm. 
503  Miller et al. Localization of  EGF Receptor Figure 3. (a and b) Cells incubated with EGF-HRP at 5°C for 30 min and then transferred to EGF-free medium at 37°C  for 15 min. Frozen 
sections were labeled with TL5  antibody-gold. The plasma membrane (pro) and peripheral endosome compartment, consisting of tubular 
cisternae (arrows) and vacuoles containing vesicles (V), are labeled. M, mitochondrion. Bar, 200 nm. 
The Journal of Cell Biology,  Volume 102, 1986  504 Figure 4. Cells preincubated  with EGF-HRP at 5"C for 30 min and then transferred to EGF-free medium at 37"C for 30 min. (a-c) Frozen 
sections  labeled with  TL5 antibody-gold;  (d-f)  frozen  sections  labeled with  EGFR1  followed by protein  A-gold. Appearance  of vesicle- 
containing vacuolar structures in the peripheral (a and d) and pericentriolar (b, c, e, and f) cytoplasm. In the peripheral elements gold particles 
label the limiting membranes and internal  vesicles, whereas in the pericentriolar  area labeling is usually associated with the internal  vesicles. 
Bar, 200 nm. 
tions of >30 min after EGF binding, EGFRI labels receptors 
within  the  acid  phosphatase-negative  MVBs  and  the  acid 
phosphatase positive lysosomes (Fig. 6). 
Discussion 
In previous reports the uptake and processing of  EGF-coupled 
ligands by the A431 cell has been studied extensively (16,  17, 
30, 41). These studies have concentrated upon the peripheral 
elements of the endosome system, and in general our obser- 
vations with  EGF-HRP confirm these earlier reports.  Com- 
paring  the  distribution  of transferrin-HRP  (and  transferrin 
receptor antibody-gold) (23) with the results obtained in the 
present  study,  it  is  clear that  upon  internalization  both  of 
these ligands become distributed throughout the same periph- 
eral endosome compartment. 
505  Miller et al. Localization  of  EGFReceptor Figure 5.  Thick (-1.0  ~,m) Epon  section  of an  EGF-stimulated cell demonstrating the  relationship between  acid phosphatase-containing 
compartments of the Golgi area.  The acid phosphatase-posidve Golgi cisternae (G) and lysosomes (large arrows)  are shown. The section is 
thick enough to accommodate the full thickness of a lysosome and demonstrates that although these acid phosphatase-positive structures lie 
close to  Golgi cisternae  and  other  vacuolar elements, they are  separate  from  them.  One  kidney-shaped  lysosome bends  around  an  acid 
phosphatase-negative vacuole, which is probably an endosomal element (small arrow), but no connection between them is evident. Bar, 200 
nm. 
After an incubation of 15-60 rain at elevated  temperature 
the EGF-HRP was transferred to elements in the juxtanuclear 
area surrounding the centrioles.  These elements included an 
elaborate reticulum of smooth-surfaced cisternae  and many 
MVBs, and although similar structures occurred in the Golgi 
area before the tracer arrived,  they were much less numerous 
and did not so obviously encircle the centrioles.  The arrange- 
ment  of these  juxtanuclear  elements  is  the  same  as  that 
identified  in a previous study using transferrin-HRP (23), and 
it is unlikely, therefore,  to have arisen specifically in response 
to EGF. However, since this kind of  arrangement is not nearly 
as extensive in untreated cells it is probably elaborated by the 
experimental protocol, which introduces a pulse oftigand into 
the  endosome.  In  a  recent  study  using  ferritin-conjugated 
transferrin  in Chinese hamster ovary cells, Yamashiro and 
Maxfield  (42) identified  a juxtanuclear complex of smooth- 
surfaced  cisternae  that was also  adjacent but separate  from 
the cisternal  stacks of the Golgi complex. A similar juxtanu- 
clear elaboration  of the  endosomal  compartment over the 
same time scale has been described in cultured granulosa cells 
(22).  In  this  system  the  movement  of endosomes  to  the 
juxtanuclear area was shown to be inhibited by microtubule- 
disrupting agents (21). 
In recent studies on KB cells HRP-EGF and HRP-transfer- 
rin internalization was followed  (40), and the EGF receptor 
was identified  by immunocytochemistry (2). In these studies 
the  labeled  ligands  and  receptors  were  also  shown  to  be 
transferred  via  a  common endosome compartment to  the 
juxtanuclear area.  A close  relationship between the labeled 
elements and microtubules in the centriolar region  was also 
noted.  However, in these  studies  on KB cells, tracers  were 
found within the Golgi area within 10 min of uptake and they 
were contained within a "trans Golgi reticulum" of cisternae 
rather than a cisternal-MVB complex. The authors suggested 
that the  trans  Golgi reticulum,  identified  by its content of 
internalized  receptors,  may correspond to  the  Golgi-endo- 
plasmic reticulum-lysosome (GERL) compartment identified 
in a variety of cell types by Novikoff and others (31, 32). A 
common characteristic  of GERL compartments is their acid 
phosphatase activity.  Our observations on the compartments 
involved in the intracellular  processing of EGF-receptor com- 
plexes in A431  cells suggest that the pericentriolar compart- 
ments we have identified  are separate  and different  from the 
acid phosphatase-positive elements lying at the trans face of 
the Golgi stack. 
In addition, our data on the distribution of  acid phosphatase 
activity suggest that internalized  ligand-receptor complexes 
transfer to  a  lysosomal compartment only after they have 
passed through the pericentriolar complex. The morphologi- 
cal insularity of the acid phosphatase-positive lysosomal ele- 
ments and the inhibitory effects that lowering the temperature 
to 20°C have on the movement of EGF and EGF receptors 
The Journal of Cell Biology,  Volume 102, 1986  506 Figure 6. Cryosection ofjuxtanuclear area in cell stimulated with EGF for 30 min at 37°C  demonstrating acid phosphatase activity and the 
distribution of EGF receptors. Gold particles demonstrate distribution of EGF receptors within multivesicular endosome elements that are acid 
phosphatase negative (small arrows) and lysosome elements containing acid phosphatase reaction product (large arrows). N, nucleus. Bar, 200 
rim. 
support earlier suggestions (7) that transfer from the  endo- 
some to the lysosome is a discontinuous step. 
The TL5  antibody used in  this study has been shown to 
identify a blood group antigenic determinant (13). It identifies 
the EGF receptor in A431  cells, because, unlike in other cell 
types, this receptor bears the same blood group antigen (9). 
However, this antigen is not specific for the EGF receptor in 
these cells because it is also found on other plasma membrane 
components such as glycolipids and possibly glycoproteins. A 
proportion of the labeling we have observed using this anti- 
body on  unstimulated  cells  must  identify  sites  other  than 
those of the EGF receptor. On unstimulated cells most of this 
label was concentrated on the plasma membrane with little 
internal labeling, and only in EGF-stimulated cells was there 
a very significant increase in the amount of label on intracel- 
lular boundaries. The available information on the selectivity 
of receptor-mediated uptake mechanisms does not, of course, 
allow  us  to  exclude  the  possibility that  antigenic  sites  on 
membrane components other than the EGF receptor may be 
internalized  in  response  to  EGF  stimulation.  However,  a 
much higher level of labeling of the plasma membrane was 
obtained  with  TL5  at  all  time  points  than  with  EGFRI, 
perhaps suggesting that most of  the non-EGF receptor binding 
sites are on the plasma membrane and are not internalized 
along with the EGF receptor. In addition, since the intracel- 
lular label  coincided  in  all  respects with  the  EGF-induced 
redistribution of EGFRI binding sites, and of EGF-HRP, we 
believe that most of the label observed in intracellular com- 
partments identifies the internalized receptor. 
The distribution of the EGF receptor within the A431  cell 
during the earlier phases of EGF stimulation closely parallels 
that of EGF ferritin described by McKanna et al. (30). Within 
the  MVBs  and  vesicle-containing vacuolar elements EGF- 
ferritin, TL5-gold, and EGFR l-protein A-gold complexes la- 
bel  the  lumenal  vesicles,  a  distribution  distinctly  different 
from that which has been observed for the transferfin receptor 
in this system (23).  Harding et al.  have, however, localized 
transferrin receptors to the internal vesicles of multivesicular 
507  Miller et al. Localization of  EGF Receptor endosomes in reticulocytes (19,  20).  In contrast to those in 
A431  cells,  however, the vesicles of reticulocyte endosomes 
are destined for release into the extracellular space when the 
endosome fuses with the plasma membrane.  The  different 
localizations of these  various  receptor  populations  within 
multivesicular endosomes would seem, therefore, to be related 
to their destinations in the different cell types. 
Throughout the endosome system  of the A431  cell,  the 
kinetics of transport and the distribution within the various 
intracellular compartments of TL5 and EGFR1  binding sites 
and EGF-HRP reaction product are the same. Our observa- 
tions  therefore  agree  with  earlier biochemical  studies  that 
showed  that  a  significant  proportion  of the  EGF  ligand- 
receptor complex remains intact throughout its intracellular 
processing. Taken together, our studies show that in A431 
cells EGF  binding  induces EGF  receptors to internalize to 
elaborate prelysosomal endosome compartments in the pe- 
ripheral and  pericentriolar cytoplasm, and  subsequently to 
the lysosome. Within  the MVBs of the pericentriolar com- 
partment the receptors are located predominantly upon lu- 
menal vesicles.  This location is different from that of inter- 
nalized transferrin receptors, which are distributed preferen- 
tially in the cisternae and on the limiting membranes of the 
pericentriolar elements. 
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